Provided by Tiger Trade Technology Pte. Ltd.

CRISPR Therapeutics AG

46.88
+0.64001.38%
Volume:1.44M
Turnover:67.89M
Market Cap:4.50B
PE:-7.25
High:47.92
Open:46.66
Low:46.40
Close:46.24
52wk High:78.48
52wk Low:30.04
Shares:95.99M
Float Shares:90.53M
Volume Ratio:0.69
T/O Rate:1.59%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-6.4700
EPS(LYR):-6.4700
ROE:-30.18%
ROA:-15.76%
PB:2.34
PE(LYR):-7.25

Loading ...

Is CRISPR Therapeutics (CRSP) Attractive After Recent Share Price Weakness And DCF Upside?

Simply Wall St.
·
Mar 22

Crispr Therapeutics Completes $600 Million Convertible Notes Offering

TIPRANKS
·
Mar 17

CRISPR Therapeutics’ CASGEVY Progress Reframes Growth And Valuation Story

Simply Wall St.
·
Mar 14

Press Release: Morningstar, Inc. Declares Quarterly Dividend of 50 Cents Per Share

Dow Jones
·
Mar 14

Cathie Wood Invests Over $10M in CRISPR and PAYP Stocks, Trims Stakes in TER and IONS

TIPRANKS
·
Mar 13

CRSP, SOLQ: Cathie Wood’s ARK ‘Buys the Dip’ in CRISPR and Solana Staking ETF

TIPRANKS
·
Mar 11

Crispr Therapeutics prices upsized convertible senior notes offering

TIPRANKS
·
Mar 11

Cathie Wood’s ARK Investment buys 281K shares of Crispr Therapeutics today

TIPRANKS
·
Mar 11

What's Going On With CRISPR Therapeutics Stock Today?

Benzinga_recent_news
·
Mar 11

Crispr Therapeutics falls -9.2%

TIPRANKS
·
Mar 11

Crispr Therapeutics Falls on $350M Senior Note Private Placement

Dow Jones
·
Mar 10

CRISPR Therapeutics plans USD 350 million convertible senior notes offering due 2031

Reuters
·
Mar 10

CRISPR Therapeutics Announces Proposed Convertible Senior Notes Offering

GlobeNewswire
·
Mar 10

What's Going On With Moderna, Capricor, Other Biotech Stocks On Monday?

Benzinga
·
Mar 10

Assessing CRISPR Therapeutics (CRSP) Valuation As Casgevy Expectations and Forecast Revisions Draw Investor Focus

Simply Wall St.
·
Mar 05

CRISPR Therapeutics Takeover Chatter With Vertex Puts Investor Tradeoffs In Focus

Simply Wall St.
·
Mar 01

Crispr Therapeutics AG Surges on Takeover Buzz and Hype

TIPRANKS
·
Feb 28

Intellia Therapeutics Eyes 2026 Pivotal CRISPR Milestone

TIPRANKS
·
Feb 28

Why Is CRISPR Therapeutics Stock Surging Thursday?

Benzinga
·
Feb 27

Is CRISPR Therapeutics (CRSP) Attractively Priced After Mixed Long Term Share Performance?

Simply Wall St.
·
Feb 26